A research team from the Scripps Research Institute in Jupiter, Florida has recently developed a lab-made molecule that could protect against HIV infection better than natural antibodies that the body produces. When tested on animals, this synthetic molecule kept four monkeys free of HIV infection despite injection of large doses of the virus.

Other virologists are not convinced that this molecule, named eCD4-lg, will work better than natural HIV antibodies, but many agree that more studies should be performed to further test the effectiveness and promise of this new molecule.

To read a Science Magazine article on this study, click here.


CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.